Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Corcept Therapeutics (CORT) Interest Coverage Ratio (2016 - 2017)

Corcept Therapeutics (CORT) has disclosed Interest Coverage Ratio for 7 consecutive years, with 130.56 as the latest value for Q2 2017.

  • For Q2 2017, Interest Coverage Ratio rose 4497.35% year-over-year to 130.56; the TTM value through Mar 2018 reached 705.2, up 8036.4%, while the annual FY2016 figure was 4.99, 529.91% up from the prior year.
  • Interest Coverage Ratio hit 130.56 in Q2 2017 for Corcept Therapeutics, up from 21.07 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 130.56 in Q2 2017 and bottomed at 12.01 in Q1 2014.
  • Average Interest Coverage Ratio over 5 years is 6.47, with a median of 1.51 recorded in 2015.
  • Year-over-year, Interest Coverage Ratio dropped 25.19% in 2014 and then skyrocketed 4497.35% in 2017.
  • Corcept Therapeutics' Interest Coverage Ratio stood at 9.17 in 2013, then soared by 58.97% to 3.76 in 2014, then surged by 163.43% to 2.39 in 2015, then skyrocketed by 411.86% to 12.21 in 2016, then soared by 969.11% to 130.56 in 2017.
  • According to Business Quant data, Interest Coverage Ratio over the past three periods came in at 130.56, 21.07, and 12.21 for Q2 2017, Q1 2017, and Q4 2016 respectively.